The Evolution of GLP-1 Drugs: A Historical Perspective It wasn’t until 1984 that the first GLP-1 was identified, although it would take years before these findings would translate into therapeutic use The identification of GLP-1 as a key incretin hormone marked a significant milestone
History of GLP-1 Medications - GLP-1 Hub So while there are a lot of wild headlines floating out there about these “new” medications, they have quite a long history of safety and effectiveness Here’s a brief history of GLP-1 agonists, how they were discovered, and what the future may hold
The Evolution of GLP-1 Receptor Agonists: A Historical Perspective In 2005, the FDA approved exenatide (Byetta), the first GLP-1 receptor agonist, marking a significant milestone in diabetes treatment Following exenatide, several other GLP-1 receptor agonists were developed, including liraglutide (Victoza), dulaglutide (Trulicity), and semaglutide (Ozempic)